Yahoo Web Search

Search results

1. • 

     Surmodics Stock Slides Following Regulatory Setback For Its SurVeil Drug-Coated Balloon

     Benzinga via Yahoo Finance· 1 year ago

     Surmodics Inc (NASDAQ: SRDX) has received a letter from the FDA related to its premarket approval...

2. • 

     After FDA Rejection, Surmodics' SurVeil Drug-Coated Balloon Scores FDA Approval

     Benzinga via Yahoo Finance· 12 months ago

     The FDA has approved Surmodics Inc's (NASDAQ: SRDX) SurVeil drug-coated balloon (DCB), a...

3. • 

     Surmodics (SRDX) Gets FDA's Formal Feedback About SurVeil DCB

     Zacks via Yahoo Finance· 1 year ago

     Surmodics, Inc. SRDX announced its receipt of positive formal feedback from the FDA regarding its...

4. • 

     Surmodics (SRDX) Rallies on FDA Approval for SurVeil DCB

     Zacks via Yahoo Finance· 12 months ago

     Surmodics' (SRDX) SurVeil DCB is indicated to treat percutaneous transluminal angioplasty in...

5. • 

     Surmodics (SRDX) Q1 Earnings Top Estimates, Revises FY24 View

     Zacks via Yahoo Finance· 4 months ago

     Surmodics, Inc. SRDX delivered break-even adjusted earnings per share (EPS) in the first quarter of...

6. • 

     Surmodics (SRDX) Stock Skids 32% on Negative Regulatory Update

     Zacks via Yahoo Finance· 1 year ago

     Shares of Surmodics, Inc. SRDX have declined 31.8% since the close on Jan 18, following...

7. • 

     Reasons to Retain Surmodics (SRDX) Stock in Your Portfolio

     Zacks via Yahoo Finance· 2 years ago

     Surmodics, Inc. SRDX is well poised for growth in the coming quarters, backed by its solid prospects...

8. • 

     Here's Why You Should Retain Surmodics (SRDX) Stock for Now

     Zacks via Yahoo Finance· 6 months ago

     Surmodics, Inc. SRDX is well-poised for growth in the coming quarters, courtesy of its solid...

9. • 

     Why Shares of Surmodics Soared on Tuesday

     Motley Fool· 12 months ago

     Shares of Surmodics (NASDAQ: SRDX) were up 16% early Tuesday afternoon as the healthcare company, which provides chemicals for in vitro diagnostic...

10. • 

      Surmodics, Inc. (NASDAQ:SRDX) Q4 2023 Earnings Call Transcript

      Insider Monkey via Yahoo Finance· 7 months ago

      Surmodics, Inc. (NASDAQ:SRDX) Q4 2023 Earnings Call Transcript November 10, 2023 Operator: Welcome...